Protalix BioTherapeutics (PLX)

• Market cap: $120M
• 1 day: -2.40%
• 5 days: -3.55%
• 1 month: 27.34%
• 3 months: 52.34%
• 6 months: 41.74%
• Year to date: -10.44%
• 1 year: 7.95%
• 5 years: -49.06%
• 10 years: -92.24%
• Sector: Healthcare
• Industry: Biological Products, Except Diagnostic Substances

Fund manager confidence

Based on 2024 Q3 regulatory filings by fund managers ($100M+ AUM)

68% more call options, than puts

Call options by funds: $62K | Put options by funds: $37K

3.13% less ownership

Funds ownership: 7.78% [Q2] → 4.65% (-3.13%) [Q3]

31% less funds holding

Funds holding: 64 [Q2] → 44 (-20) [Q3]

48% less capital invested

Capital invested by funds: $6.67M [Q2] → $3.47M (-$3.2M) [Q3]

71% less first-time investments, than exits

New positions opened: 8 | Existing positions closed: 28

74% less repeat investments, than reductions

Existing positions increased: 5 | Existing positions reduced: 19